OVA Peptide (257-264)
OVA Peptide (257-264) is a class I (Kb) -restricted peptide epitope of OVA, an octameric peptide can be from ovalbumin presented by the class I MHC molecule, H-2Kb.
Product Specifications
CAS Number
[138831-86-4]
UNSPSC
12352209
Target
MHC
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/OVA_Peptide_257-264.html
Purity
99.65
Solubility
0.1% TFA in Water : 1.83 mg/mL (ultrasonic) |DMSO : 40 mg/mL (ultrasonic; adjust pH to 3 with 1 M HCl)
Smiles
O=C(N[C@@H]([C@@H](C)CC)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC(N)=O)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)[C@H](CO)N
Molecular Formula
C45H74N10O13
Molecular Weight
963.13
References & Citations
[1]Wick MJ, et al. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. Eur J Immunol. 1996 Nov;26 (11) :2790-9.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Citation 01
Cell Commun Signal. 2024 Aug 27;22 (1) :413.|Cell Death Dis. 2025 Jun 20;16 (1) :462.|Nat Commun. 2025 Sep 2;16 (1) :8181.|Nutrients. 2024 Oct 22;16 (21) :3577.|OncoImmunology. 2022 Feb 9;11 (1) :2034257.|Pathol Res Pract. 2025 Apr 10:270:155975.|Adv Sci (Weinh) . 2024 Dec;11 (45) :e2404756.|BIO Web of Conferences. 2025 Jul 2.|bioRxiv. 2023 Jan 31.|Cancer Cell. 2025 Jul 30:S1535-6108 (25) 00320-4.|Mol Cell. 2024 Mar 21;84 (6) :1120-1138.e8.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
